Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Curesense Therapeutics Private Limited, is an unlisted private company incorporated on 26 November, 2020. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 1.00 cr and the total paid-up capital is INR 1.00 cr.
The current status of Curesense Therapeutics Private Limited is - Active.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
Latest financials
Latest annual return
MoA and AoA
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sujit Sohanlal Jain | 01463586 | 4 years |
| Director | Hasmukh Sohanraj Rawal | 03566044 | 4 years |
| Director | Shailendra Balasaheb Kawade | 07527160 | 4 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| RUDRANSH ENERGY PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Madhya Pradesh |
| NETSURF COMMUNICATIONS PRIVATE LIMITED |
Active
|
25.0 L | 1 | Maharashtra |
| NETSURF RESEARCH LABS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| DUO RESTAURANTS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Maharashtra |
| CINE TALKIES VENTURES PRIVATE LIMITED |
Not available for efiling
|
1.0 L | 1 | Maharashtra |
| ASTAR AVIATION IFSC PRIVATE LIMITED |
Under Process of Striking Off
|
2.0 Cr | 1 | Gujarat |
| SEVA INFOTECH PRIVATE LIMITED |
Active
|
55.0 L | 2 | Maharashtra |
| NETSURF BIO-TECH PRIVATE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| PURETATVA ORGANICS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| Westerra Realty LLP |
Active
|
1.0 L | 1 | Maharashtra |
| PANCHSHIL LABS LLP PARTNERSHIP |
Under process of striking off
|
1.0 L | 1 | Maharashtra |
| PROGRESSIVE STRATEGIES LLP |
Active
|
1.0 L | 1 | sh |
| SIEEGER BIOTECH LLP |
Active
|
1.0 L | 1 | Maharashtra |
| EKAAKSHARA ENTERPRISES LLP |
Active
|
40,000.0 | 1 | Maharashtra |
| DUO HOSPITALITY LLP |
Active
|
1.0 L | 1 | Maharashtra |
| NETSURF ENTERTAINMENT LLP |
Active
|
10,000.0 | 1 | Maharashtra |
| BIONOTES LLP |
Active
|
20,000.0 | 2 | Maharashtra |
| AJAY BIO-TECH (INDIA) LIMITED |
Active
|
2.1 Cr | 1 | Maharashtra |
| MYLAB DISCOVERY SOLUTIONS PRIVATE LIMITED |
Active
|
10.0 Cr | 3 | Maharashtra |
| KISAN LIVESTOCK AND CROP FORENSIC LLP |
Active
|
1.0 L | 2 | sh |
| MYLAB LIFESOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| 4A FINANCIAL TECHNOLOGIES PRIVATE LIMITED |
Active
|
17.5 L | 1 | Maharashtra |
| ETERNAL SOFTECH OPPORTUNITIES LLP |
Active
|
1.0 L | 1 | Maharashtra |
| IAES VENTURES LLP |
Active
|
1.0 L | 1 | Haryana |
The incorporation date of CURESENSE THERAPEUTICS PRIVATE LIMITED is 26 November, 2020
The authorized share capital of CURESENSE THERAPEUTICS PRIVATE LIMITED is INR ₹ 1.0 Cr.
The paid-up capital of CURESENSE THERAPEUTICS PRIVATE LIMITED is INR ₹ 1.0 Cr.
The registered address of CURESENSE THERAPEUTICS PRIVATE LIMITED is Baner Pashan Link Rd Sno 137/1/1 Mont Vert Biarritz Pashan Link Rd Pune Pune Maharashtra - 411021
The CIN number of CURESENSE THERAPEUTICS PRIVATE LIMITED is U24230PN2020PTC196328.
Expand
Delete
Collapse
See
details
